[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613848":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":45,"collaborators":20,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":20,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":29,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Pusan National University Yangsan Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Parkinson","EXPERIMENTAL","Participants received whole-body PBM therapy once daily (20 minutes per session), three times per week, for approximately 10 weeks, totaling 30 sessions.",[13],"Device: Photobiomodulation",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Photobiomodulation","Participants received whole-body PBM therapy over approximately 10 weeks (three sessions per week, once daily, 20 minutes per session), with each session using a randomly selected wavelength of either 660 nm, 850 nm, or 940 nm (±20%).",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Jisoo Baik","CONTACT","082+055-360-4159","zisoo@pusan.ac.kr",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":20,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Yangsan","Gyeongsangnam-do","50612","South Korea",{"type":35,"coordinates":36},"Point",[37,38],129.03358,35.34199,{"lat":38,"lon":37},[41],{"name":42,"role":24,"phone":43,"phoneExt":20,"email":44},"Youjin Jeong","+82-55-360-4720","gamza33@naver.com",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Yong-il Shin","Professor","100613848","whole-body-photobiomodulation-for-motor-and-cognitive-changes-in-parkinsons-disease-100613848",false,"NCT07271927","Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease","Evaluation Study of the Effects and Safety of Whole-Body Photobiomodulation Therapy on Motor and Cognitive Changes in Patients With Parkinson's Disease","PBM","Inclusion Criteria:\n\n* Individuals diagnosed with Parkinson's disease at Hoehn and Yahr stages 1-3 based on medical history and examination\n* Adults aged 40 years or older\n* Individuals able to walk independently\n\nExclusion Criteria:\n\n* Individuals with severe cognitive impairment (Korean Mini-Mental State Examination \\[K-MMSE\\] score ≤ 9) making it difficult to understand and perform tasks\n* Patients with dementia other than Parkinson's disease dementia\n* Individuals with implanted medical or other electronic devices\n* Individuals with severe neuropsychiatric disorders\n* Individuals treated for alcohol dependence within 6 months prior to screening\n* Individuals with a history of suicide attempts\n* Individuals with a history of seizures\n* Individuals experiencing dyspnea while sitting at rest\n* Individuals with visual impairment preventing them from reading ordinary text even with corrective lenses\n* Individuals with hearing impairment preventing them from understanding conversation even with a hearing aid\n* Individuals who have participated in two or more clinical trials in the same year or in another clinical trial within the past 6 months\n* Women and men of childbearing potential who are planning pregnancy during the trial or who do not agree to use appropriate contraceptive methods\n* Pregnant or breastfeeding women\n* Individuals deemed medically inappropriate for participation by the principal investigator or study staff based on clinically significant findings not otherwise specified above","ALL","40 Years",{"count":60,"type":61},15,"ESTIMATED","INTERVENTIONAL",[64],"NA","This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about three sessions per week, once daily, 20 minutes per session) in patients with Parkinson's disease.",[67],"PARKINSON DISEASE (Disorder)",[17,69,70,71,72],"Parkinson disease","cognition","motor function","light theraphy","2025-11-26",{"date":75,"type":76},"2025-12-09","ACTUAL",{"date":78,"type":76},"2025-02-12",{"date":80,"type":61},"2025-12-31",{"name":5,"class":6},1]